Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating kidney function in kidney transplant recipients on anti-rejection therapy including tacrolimus, with or without sirolimus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED